NIH Awards $1.8M to Pain Therapeutics for Work Toward a Diagnostic Blood Test for Alzheimer’s

NIH Awards $1.8M to Pain Therapeutics for Work Toward a Diagnostic Blood Test for Alzheimer’s
Pain Therapeutics has received a $1.8 million research grant from the National Institutes of Health (NIH) to support the development of a technology to diagnose Alzheimer’s disease (AD) in early stages based on a simple blood test. AD is a progressive disorder, meaning it slowly destroys memory and cognitive skills. This damage is known to start a decade

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *